Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Determinaton of Changes in the Endometrial Gene Expression Profile Induced by Exogenous Progesterone After Post-ovulatory Administration of Mifepristone

NCT06616077 is registered in ClinicalTrials.gov with Reproductive Health Research Insritute, Chile as lead sponsor.

NCT NCT06616077
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06616077 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Determinaton of Changes in the Endometrial Gene Expression Profile Induced by Exogenous Progesterone After Post-ovulatory Administration of Mifepristone
Lead sponsor
Reproductive Health Research Insritute, Chile
Phase
Phase 1
Overall status
Completed
Start date
June 7, 2022
Completion date
May 8, 2023
Enrollment
9 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

endometrial endocrine regulation, progesterone supplementation in women after mifepristone